Brief: Tricida Announces FDA Acceptance Of New Drug Application For Veverimer
Nov 14 (Reuters) - Tricida Inc TCDA.O :
* TRICIDA ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION
FOR
VEVERIMER
* TRICIDA INC - FDA ALSO STATED THAT NO FILING REVIEW ISSUES
WERE
IDENTIFIED
* TRICIDA INC - COMMERCIAL TEAM IS TARGETING A SUCCESSFUL
LAUNCH
WITH A FULL QUARTER OF REVENUE IN Q4 OF 2020
* TRICIDA INC - FDA ASSIGNED PDUFA GOAL DATE OF AUGUST 22,
2020
Source text for Eikon: ID:nBwc0wmhna
Further company coverage: TCDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tricida
See all newsBrief: Tricida Inc - On March 9, Company And Renibus Consummated Sale Of Certain Assets
Brief: Tricida Inc Receives Notice Of Delisting From Nasdaq
Brief: Tricida Inc Filed Voluntary Petition For Relief Under Chapter 11
Brief: Tricida - On December 19, 2022, Tricida Received An Additional Letter From Patheon Referencing The Purported Termination Notice From December 7, 2022
Brief: Tricida Inc - On December 6, Received Notice From Nasdaq That Co Is Not Been In Compliance With Minimum Bid Price Requirement - Filing